THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Koc, Basak [1 ,2 ]
Zulfikar, Bulent [1 ,2 ]
机构：
[1] IU Cerrahpasa Med Fac, Istanbul, Turkey
[2] Inst Oncol, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
689
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [21] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [22] Real-World Use of First and Second Generation Tyrosine Kinase Inhibitors Pre- and Post-Hematopoietic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Takiar, Radhika
    Perissinotti, Anthony J.
    Marini, Bernard L.
    Benitez-Colon, Lydia
    Burke, Patrick W.
    Crouch, Ashley
    Bixby, Dale
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S190 - S190
  • [23] Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
    Leoni, Veronica
    Biondi, Andrea
    HAEMATOLOGICA, 2015, 100 (03) : 295 - 299
  • [24] The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphoblastic leukemia
    Wu, Xiaoxia
    Lu, Shenqi
    Zhang, Xinhui
    Yang, Zhen
    Sun, Aining
    Wu, Depei
    Zhou, Huifen
    Miao, Miao
    CANCER MEDICINE, 2024, 13 (17):
  • [25] PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. IMPROVED OUTCOME IN THE TYROSINE KINASE INHIBITOR ERA
    Dima, M.
    Cucuianu, A.
    Patiu, M.
    Petrov, L.
    Dohner, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 493 - 493
  • [26] Acute lymphoblastic leukemia with Philadelphia chromosome: treatment with kinase inhibitors
    Thomas, Xavier
    BULLETIN DU CANCER, 2007, 94 (10) : 871 - 880
  • [27] Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    Kim, Theo D.
    Schwarz, Michaela
    Nogai, Hendrik
    Grille, Peggy
    Westermann, Joerg
    Ploeckinger, Ursula
    Braun, Doreen
    Schweizer, Ulrich
    Arnold, Renate
    Doerken, Bernd
    le Coutre, Philipp
    THYROID, 2010, 20 (11) : 1209 - 1214
  • [28] THYROID DYSFUNCTION CAUSED BY SECOND-GENERATION TYROSINE KINASE INHIBITORS IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA
    Tothova, E.
    Kafkova, A.
    Stejskal, L.
    Hajek, R.
    HAEMATOLOGICA, 2016, 101 : 740 - 740
  • [29] Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia
    Jabbour, Elias
    DerSarkissian, Maral
    Duh, Mei Sheng
    McCormick, Nora
    Cheng, Wendy Y.
    McGarry, Lisa J.
    Souroutzidis, Ariadne
    Huang, Hui
    O'Brien, Susan
    Ravandi, Farhad
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 257 - 265
  • [30] Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Akahoshi, Yu
    Nishiwaki, Satoshi
    Mizuta, Shuichi
    Ohashi, Kazuteru
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Fukuda, Takahiro
    Ozawa, Yukiyasu
    Takahashi, Satoshi
    Onizuka, Makoto
    Shiratori, Souichi
    Nakamae, Hirohisa
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kako, Shinichi
    CANCER SCIENCE, 2019, 110 (10) : 3255 - 3266
12345